In the News

Links to recent media coverage about Pervasis are found below.

 

2011

November 14, 2011

Boston Globe
"Biotech firms target tumors' neighborhoods"

September 15, 2011

Boston Business Journal
"MIT's Langer wins 'Golden Globe' of science "

September 7, 2011

Nature Medicine
"Taking tissue engineering to heart"

May/June 2011

MIT technology review
"Keeping Cancer in Check"

May 1, 2011

Pharmaceuticals Approvals Monthly
"Variety of Novel Approaches Marks Next-Gen Cancer Therapies at AACR"

April 7, 2011

BioWorld Today
"AACR Roundup"

March 1, 2011

Boston Globe
"Pervasis drug gets orphan status in Europe" 

March 1, 2011

Mass High Tech
"Pervasis drug candidate gets EU orphan drug status" 

February 8, 2011

Mass High Tech
"Pervasis hemodialysis treatment lands FDA fast-track review" 

February 3, 2011

SciBX
"Implanting tumor control" 

February 1, 2011

Drug Discovery & Development
"The Challenge of Cell Therapies"

February 1, 2011

Xconomy
"Pervasis in "Advanced" Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says" 

January 20, 2011

Mass High Tech
"Pervasis broadens to cancer therapeutics, eyes new financings" 

January 20, 2011

BioWorld Today
"Other News To Note: Pervasis Therapeutics" 

January 19, 2011

MedNous
"Pervasis Therapeutics explores endothelial cell-based approach to cancer" 

January 19, 2011

MIT media relations
"MIT scientists discover cancer-fighting role for cells" 

 

2010

November 10-17, 2010

Paris Match
"PAD: A Cell Therapy Against Recurrence" [english]

October 27, 2010

Mass High Tech
"MHT All-Star Frederic Chereau: Working to make lives better"

August 31, 2010

Mass High Tech
"MHT All-Stars"

August 26, 2010

Drug Discovery & Development
"A Novel Approach to Treating Peripheral Arterial Disease"

August 18, 2010

Mass High Tech
 "Regenerative medicine gets on a profitable roll" 

July / August 2010

Drug Delivery Technology
"The Power of the Endothelium: Novel Delivery Approaches to Promoting Vascular Healing"

April 23, 2010

Fierce Biotech
 "Regenerative medicine could be $20B market in 15 years" 

April 14, 2010

Mass High Tech
 "BIOMEDevice Forum panelists talk of life sciences' cross sections" 

March 26, 2010

New York Times
 "Replacement Bones, Grown to Order in the Lab" 

February 26, 2010

Mass High Tech
 "BioForum panelists make case for partnership credibility" 

February 2, 2010

The Boston Business Journal
 "FDA clears track for Pervasis drug trial" 

 

2009

September 16, 2009

The Boston Globe
“Pervasis completes initial closing of $17m round”

May 2009

Scientific American
“Progress in Tissue Engineering” [PDF]

 

2008

December 5, 2008

Mass High Tech
“The Mover: Frederic Chereau brings big-biotech experience to startup Pervasis Therapeutics” [PDF]

October 21, 2008

Xconomy
“Pervasis, Maker of Product to Heal Blood Vessels, Hires Genzyme Exec as First CEO” [PDF]

October 21, 2008

Mass High Tech
“Former Genzyme exec heads Pervasis Therapeutics"

October 21 , 2008

The Boston Globe
“Pervasis appoints chief executive”

October 21, 2008

Boston Business Journal
“Genzyme exec becomes new Pervasis CEO”

May 22, 2008

Science
“Engineering a Healing"

May 4, 2008

MIT news
“MIT researchers find novel way to repair airway injuries”

January 22, 2008

The Regeneration Station
“Pervasis Advances Tissue Engineered Products for Vascular Health”

January 15, 2008

The Boston Globe
“Pervasis secures additional funding”

January 15, 2008

Boston Business Journal
“Pervasis Therapeutics closes on $9.75M funding round”

January 15, 2008

Mass High Tech
“Pervasis to pump up blood vessel repair tech with $10M round”

January 15, 2008

Xconomy
“Pervasis Picks Up $9.75M”

 

2007

June 26, 2007

Technology Review
“Healing Blood Vessels”

March 20, 2007

Boston Business Journal
“Pervasis Starts Phase II Trials on Vascular Drug”

 

2006

November 2006

Cardiovascular Innovations
“Cellular ‘wrap’ may help regenerate damaged vessels”

October 20, 2006

Mass High Tech
“Cell Culture”

October 2, 2006

The Boston Globe
“Cells, Not Tools, May Help Fix Arteries” [PDF]